Optimal Bayesian-feasible dose escalation for cancer phase I trials
type: Item
instance of: scholarly article
title: Optimal Bayesian-feasible dose escalation for cancer phase I trials
zbMATH Open document ID: 0903.62064
DOI: 10.1016/S0167-7152(98)00016-9
published in: Statistics \& Probability Letters
publication date: 1999-01-06T00:00:00Z
Mathematics Subject Classification ID: 62L05
Mathematics Subject Classification ID: 62P10
Mathematics Subject Classification ID: 62F15
zbMATH DE Number: 1202793
zbMATH Keywords: Bayesian adaptive procedure
zbMATH Keywords: constrained optimization
zbMATH Keywords: Bayesian feasible scheme
zbMATH Keywords: dose escalation scheme
zbMATH Keywords: cancer phase I clinical trials
author: S. Zacks
author: André Rogatko
author: James S. Babb
MaRDI profile type: Publication
cites work: Continual Reassessment Method: A Practical Design for Phase 1 Clinical Trials in Cancer
cites work: Q3321154
cites work: Design and Analysis of Phase I Clinical Trials
cites work: Selection of Dose Levels for Estimating a Percentage Point of a Logistic Quantal Response Curve
cites work: Q4212125
cites work: Q4061817
full work available at URL: s0167-7152(98)00016-9
OpenAlex ID: W2063214645
description: scientific article; zbMATH DE number 1202793